logo-loader
FinanceInvestments and investor services
WeedMD Inc.

Eight Capital bullish on WeedMD, citing a positive 2019 outlook

Analysts gave the Canadian medical cannabis grower a Buy rating and a price target of C$4.50

cannabis
WeedMD owns and operates two facilities in Ontario to produce and distribute medical-grade cannabis

Eight Capital is bullish on WeedMD Inc (OTCMKTS:WDDMF), citing a positive 2019 outlook.

Analysts on Friday gave the Canadian medical cannabis grower a Buy rating and a price target of C$4.50.

Eight Capital issued its note hours after WeedMD released first-quarter earnings, showing a 23% quarter-over-quarter increase in revenue to C$3.3 million. The rating firm had expected C$3.5 million in revenue but blamed the slight miss on a lower average-price-per gram, which was offset by higher-than-expected volumes.

WeedMD sold 793 kilograms of dried cannabis, representing an increase of 46% from the previous quarter. Analysts estimated the company would sell 625 kgs.

READ: WeedMD gets coveted outdoor pot cultivation licence from Health Canada

WeedMD, based in Aylmer, Ontario, owns and operates two facilities in southwestern Ontario to produce and distribute medical-grade cannabis.

The Aylmer facility houses 26,000 square feet of grow and extraction space on an expandable site across four acres of land, while its 158-acre Strathroy, Ontario facility includes both indoor and outdoor grow capacity. The company on Friday secured Health Canada approval for 27 acres of low-cost, outdoor cultivation at Strathroy.

“Moving  forward, the company expects revenue growth to continue throughout the balance of 2019 as its Strathroy site ramps up and its Aylmer extraction facility comes online in mid-summer,” analysts wrote.

The ratings firm also cited WeedMd’s plan to start processing 70,000 kgs annually at the Aylmer plant.

“We believe the company is positioning itself well for the derivatives market in 2020,” Eight Capital wrote.

The company's stock on Friday closed up 1.45% to C$1.39 a share in Toronto. 

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

Quick facts: WeedMD Inc.

Price: $1.54

Market: TSX-V
Market Cap: $175.21 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of WeedMD Inc. named herein, including the promotion by the Company of WeedMD Inc. in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

There's a new cannabis ETF in town: Innovation Shares launches new,...

Innovation Shares LLC Managing Director Matt Markiewicz tells Proactive Investors the exchange-traded fund company has recently launched The Cannabis ETF (NYSE:THCX). Markiewicz says the passively managed ETF will focus on 35 companies in the legal marijuana space, including Radient...

on 07/12/2019

2 min read